The application of in silico modeling to predict the in vivo outcome of an oral drug product is gaining a lot of interest. Fully relying on these models as a surrogate tool requires continuous optimization and validation. To do so, intraluminal and systemic data are desirable to judge the predicted outcomes.
openaire +2 more sources
Proteomic blood-based biomarkers of brain damage in traumatic brain injury: are they suitable surrogate endpoints for cerebral pressure autoregulatory-guided therapy? [PDF]
Kevci R +14 more
europepmc +1 more source
A review of OSP suite PBBM capabilities: looking ahead
Stephan Schaller +3 more
openaire +1 more source
Calculating the carbon footprint (CF) holds paramount importance in today’s world as it provides a tangible measure of our impact on the environment.
Yavuzdeger, Abdurrahman +9 more
core +1 more source
Mechanism-Based Pharmacokinetic and Pharmacodynamic Modeling. [PDF]
Świerczek A.
europepmc +1 more source
Narrow Therapeutic Index Drugs: Regulatory Frameworks, Bioequivalence, and Model-Informed Precision Dosing. [PDF]
Liu M +7 more
europepmc +1 more source
Physiologically Based Pharmacokinetic Modeling of Efavirenz Nanoparticles: from Animal Model to Human Extrapolation. [PDF]
da Silva TM +8 more
europepmc +1 more source
Evaluation of USP 3 Apparatus to Develop Biopredictive Fasted and Fed Dissolution Methods for Extended-Release Desvenlafaxine Succinate Tablets. [PDF]
Carapeto GV +4 more
europepmc +1 more source
Η χορήγηση φαρμάκων από το στόμα είναι η προτιμότερη οδός χορήγησης σε σχέση με τις άλλες οδούς λόγω της υψηλής συμμόρφωσης των ασθενών. Η ανάπτυξη νέων per os χορηγούμενων φαρμακευτικών προϊόντων συνοδεύεται από προκλήσεις δεδομένου ότι η απορρόφηση από το γαστρεντερικό σύστημα είναι μια πολύπλοκη διαδικασία ιδιαίτερα για τις δραστικές φαρμακευτικές ...
Vrenken Paul, Vrenken Paul
openaire +1 more source
Development of in vitro-in vivo correlation for establishing patient-centric quality standards of dissolution for lamotrigine extended-release tablets. [PDF]
Zidan A +5 more
europepmc +1 more source

